DK0682015T3 - Piperidinderivater og anti-blodplademidler indeholdende dem - Google Patents
Piperidinderivater og anti-blodplademidler indeholdende demInfo
- Publication number
- DK0682015T3 DK0682015T3 DK95302647T DK95302647T DK0682015T3 DK 0682015 T3 DK0682015 T3 DK 0682015T3 DK 95302647 T DK95302647 T DK 95302647T DK 95302647 T DK95302647 T DK 95302647T DK 0682015 T3 DK0682015 T3 DK 0682015T3
- Authority
- DK
- Denmark
- Prior art keywords
- carbon atoms
- substituted
- unsubstituted
- group
- organic groups
- Prior art date
Links
- 150000003053 piperidines Chemical class 0.000 title abstract 2
- 229940127218 antiplatelet drug Drugs 0.000 title 1
- 239000000106 platelet aggregation inhibitor Substances 0.000 title 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 3
- 125000000962 organic group Chemical group 0.000 abstract 2
- -1 piperidino, morpholinyl Chemical group 0.000 abstract 2
- 206010003210 Arteriosclerosis Diseases 0.000 abstract 1
- 208000019695 Migraine disease Diseases 0.000 abstract 1
- 206010061876 Obstruction Diseases 0.000 abstract 1
- 208000007536 Thrombosis Diseases 0.000 abstract 1
- 230000000702 anti-platelet effect Effects 0.000 abstract 1
- 239000003146 anticoagulant agent Substances 0.000 abstract 1
- 208000011775 arteriosclerosis disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 230000000302 ischemic effect Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000004089 microcirculation Effects 0.000 abstract 1
- 206010027599 migraine Diseases 0.000 abstract 1
- 125000004193 piperazinyl group Chemical group 0.000 abstract 1
- 125000005936 piperidyl group Chemical group 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000003215 serotonin 5-HT2 receptor antagonist Substances 0.000 abstract 1
- 125000005415 substituted alkoxy group Chemical group 0.000 abstract 1
- 125000000547 substituted alkyl group Chemical group 0.000 abstract 1
- 125000005346 substituted cycloalkyl group Chemical group 0.000 abstract 1
- 125000005505 thiomorpholino group Chemical group 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/541—Non-condensed thiazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Vascular Medicine (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP8149994 | 1994-04-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0682015T3 true DK0682015T3 (da) | 2003-01-27 |
Family
ID=13748073
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK95302647T DK0682015T3 (da) | 1994-04-20 | 1995-04-20 | Piperidinderivater og anti-blodplademidler indeholdende dem |
Country Status (12)
| Country | Link |
|---|---|
| US (4) | US5932593A (da) |
| EP (2) | EP1103544A3 (da) |
| JP (1) | JP2001002571A (da) |
| KR (1) | KR100351012B1 (da) |
| CN (1) | CN1056143C (da) |
| AT (1) | ATE204566T1 (da) |
| CA (1) | CA2147429A1 (da) |
| DE (1) | DE69522257T2 (da) |
| DK (1) | DK0682015T3 (da) |
| ES (1) | ES2161828T3 (da) |
| PT (1) | PT682015E (da) |
| TW (1) | TW366343B (da) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100351012B1 (ko) * | 1994-04-20 | 2002-12-26 | 아지노모토 가부시키가이샤 | 피페리딘유도체및이를함유하는항혈소판제 |
| US5801175A (en) | 1995-04-07 | 1998-09-01 | Schering Corporation | Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
| JP3779349B2 (ja) * | 1995-04-24 | 2006-05-24 | 興和株式会社 | ピペリジン誘導体 |
| JP2914324B2 (ja) * | 1995-10-23 | 1999-06-28 | 味の素株式会社 | ピペリジン誘導体の結晶並びにその製造中間体及び製造方法 |
| WO1998037888A1 (fr) * | 1997-02-27 | 1998-09-03 | Ajinomoto Co., Inc. | Agent thrombolytique |
| AU6520498A (en) * | 1997-04-09 | 1998-10-30 | Ajinomoto Co., Inc. | Process for producing piperidinecarboxylic acid amides |
| AU7907298A (en) * | 1997-06-25 | 1999-01-19 | Novo Nordisk A/S | Novel heterocyclic compounds |
| JP2000247882A (ja) | 1999-02-26 | 2000-09-12 | Ajinomoto Co Inc | 間歇性跛行治療薬 |
| US6262076B1 (en) * | 2000-01-28 | 2001-07-17 | Ajinomoto Co., Inc. | Pharmaceutical composition for use in the treatment of diabetic neuropathy |
| JP4337138B2 (ja) | 2001-08-31 | 2009-09-30 | 味の素株式会社 | 新規ジアリールアルケン誘導体及び新規ジアリールアルカン誘導体 |
| JP2005298340A (ja) * | 2002-03-13 | 2005-10-27 | Ajinomoto Co Inc | 疼痛治療薬 |
| US7524864B2 (en) * | 2004-04-23 | 2009-04-28 | Hypnion, Inc. | Methods of treating sleep disorders |
| CA2871766C (en) | 2011-12-08 | 2020-06-16 | The Board Of Regents Of The University Of Texas System | Piperidine-based small molecule 5-hydroxytryptamine 2c receptor (5-ht2cr) allosteric modulators |
| WO2018114354A1 (en) | 2016-12-23 | 2018-06-28 | Unilever Plc | Freezer cabinet and method for adapting a freezer cabinet |
| US11333425B2 (en) | 2016-12-23 | 2022-05-17 | Conopco, Inc. | Freezer cabinet and method for adapting a freezer cabinet |
| KR102236857B1 (ko) | 2018-12-28 | 2021-04-06 | 강원대학교산학협력단 | 시프로헵타딘 유도체, 이의 제조방법 및 이를 포함하는 식욕 촉진용 조성물 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1322527A (fr) * | 1961-05-06 | 1963-03-29 | Sandoz Sa | Nouveaux dérivés du thiaxanthène et leur préparation |
| FR2620121B1 (fr) * | 1987-09-09 | 1990-01-05 | Synthelabo | ((pyrimidinyl-2)-aminoalkyl)-1 piperidines, leur preparation et leur application en therapeutique |
| US5250681A (en) * | 1988-06-02 | 1993-10-05 | Ajinomoto Co., Inc. | Piperidine derivatives and hypotensives containing the same |
| US5393890A (en) * | 1988-06-02 | 1995-02-28 | Ajinomoto Co., Inc. | Piperidine derivatives and hypotensives containing the same |
| CA2004211A1 (en) * | 1988-11-30 | 1990-05-31 | Masataka Syoji | Piperidine derivatives and hyportensives containing the same |
| AU620996B2 (en) * | 1989-07-04 | 1992-02-27 | Hokuriku Pharmaceutical Co. Ltd. | 4-{(dibenzocycloheptene) or (dibenzoxepin)}-1-substituted piperidines |
| EP0479601B1 (en) * | 1990-10-05 | 1999-12-15 | Ajinomoto Co., Inc. | Piperidine derivatives and their use as antiarrhythmic agents |
| JP2961995B2 (ja) * | 1991-10-08 | 1999-10-12 | 味の素株式会社 | ピペリジン誘導体およびこれを含有する抗不整脈薬 |
| KR100351012B1 (ko) * | 1994-04-20 | 2002-12-26 | 아지노모토 가부시키가이샤 | 피페리딘유도체및이를함유하는항혈소판제 |
-
1995
- 1995-04-19 KR KR1019950009172A patent/KR100351012B1/ko not_active IP Right Cessation
- 1995-04-19 TW TW084103844A patent/TW366343B/zh active
- 1995-04-20 PT PT95302647T patent/PT682015E/pt unknown
- 1995-04-20 CN CN95104192A patent/CN1056143C/zh not_active Expired - Fee Related
- 1995-04-20 EP EP01103999A patent/EP1103544A3/en not_active Withdrawn
- 1995-04-20 DE DE69522257T patent/DE69522257T2/de not_active Expired - Fee Related
- 1995-04-20 AT AT95302647T patent/ATE204566T1/de not_active IP Right Cessation
- 1995-04-20 EP EP95302647A patent/EP0682015B1/en not_active Expired - Lifetime
- 1995-04-20 CA CA002147429A patent/CA2147429A1/en not_active Abandoned
- 1995-04-20 ES ES95302647T patent/ES2161828T3/es not_active Expired - Lifetime
- 1995-04-20 DK DK95302647T patent/DK0682015T3/da active
-
1997
- 1997-08-25 US US08/917,180 patent/US5932593A/en not_active Expired - Fee Related
-
1999
- 1999-02-08 US US09/245,846 patent/US20020019533A1/en not_active Abandoned
-
2000
- 2000-06-12 JP JP2000175490A patent/JP2001002571A/ja active Pending
-
2002
- 2002-03-21 US US10/101,980 patent/US20020147195A1/en not_active Abandoned
-
2003
- 2003-09-10 US US10/658,322 patent/US20040063701A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| ATE204566T1 (de) | 2001-09-15 |
| EP1103544A3 (en) | 2001-06-06 |
| PT682015E (pt) | 2002-01-30 |
| CN1056143C (zh) | 2000-09-06 |
| US5932593A (en) | 1999-08-03 |
| TW366343B (en) | 1999-08-11 |
| KR950031071A (ko) | 1995-12-18 |
| DE69522257D1 (de) | 2001-09-27 |
| KR100351012B1 (ko) | 2002-12-26 |
| EP1103544A2 (en) | 2001-05-30 |
| US20020147195A1 (en) | 2002-10-10 |
| EP0682015B1 (en) | 2001-08-22 |
| US20020019533A1 (en) | 2002-02-14 |
| CN1112560A (zh) | 1995-11-29 |
| US20040063701A1 (en) | 2004-04-01 |
| CA2147429A1 (en) | 1995-10-21 |
| ES2161828T3 (es) | 2001-12-16 |
| DE69522257T2 (de) | 2002-06-13 |
| EP0682015A1 (en) | 1995-11-15 |
| JP2001002571A (ja) | 2001-01-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0682015T3 (da) | Piperidinderivater og anti-blodplademidler indeholdende dem | |
| MY107756A (en) | Piperazine derivatives. | |
| ATE233256T1 (de) | 2-pyrimidinamin derivaten und verfahrens zu deren herstellung | |
| HUT53106A (en) | Process for producing new thienotriazolo-1,4-diazepine derivatives and pharmaceutical compositions comprising such compounds | |
| ATE440096T1 (de) | Substituierte thiazolderivate mit 3- pyridylgruppen, verfahren zu deren herstellung und deren verwendung | |
| FI952424A (fi) | 11,21-bisfenyyli-19-norpregaanijohdannaisia | |
| NO932607D0 (no) | Piperidinderivater og anvendelse av disse | |
| MY133108A (en) | Muscarinic antagonists | |
| HUT59394A (en) | Process for producing piperazine derivatives and pharmaceutical compositions comprising same | |
| CS101792A3 (en) | Novel antihistaminics without sedative effects, derived frombenzimidazoles | |
| FR2655545B1 (fr) | Nouvelle application therapeutique des derives des fluoroquinolones. | |
| BR0208823A (pt) | Composto, método de tratamento de distúrbios que são remediados ou aliviados pela atividade de agonista de vasopressina em um mamìfero necessitando do mesmo, e, composição farmacêutica | |
| NO933435L (no) | Piperidinderivater, deres fremstilling og anvendelse | |
| DK0888356T3 (da) | Kondenserede 2,3-benzodiazepinderivater og deres anvendelse som AMPA-receptohaemmere | |
| MA20369A1 (fr) | Compositions a base de derives de la piperidine ,nouveaux derives de la piperidine et leurs procedes de preparation | |
| HUP0002659A2 (hu) | Benzo-5,6-ciklohepta[1,2-b]piridin-származékok, e vegyületeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| IL115085A (en) | Piperazine bicyclic carboxamide derivatives their preparation and pharmaceutical compositions containing them | |
| NO893039L (no) | Bruk av imidazopyrazol-derivater som analgesiske og antiinflammatoriske midler. | |
| DE3862660D1 (de) | 2,3-dihydro-2-oxo-3-benzofuranyl-essigsaeurederivate und diese enthaltende arzneimittel. | |
| DE68919869D1 (de) | Cephalosporinderivate. | |
| DK0940401T3 (da) | 2-Carbonylthiazolderivater og anvendelse deraf | |
| DK163922C (da) | 2,3-dihydro-3-phenyl-2-benzofuranonderivater, fremgangsmaader til deres fremstilling og farmaceutiske midler indeholdende dem | |
| MY101756A (en) | Dichloroaniline derivatives | |
| ECSP003505A (es) | Derivados de 4-fenil- pirimidina | |
| TW257758B (en) | Piperazine derivatives (1) |